| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023 | 1823 | 2023 |
| DC isoketal-modified proteins activate T cells and promote hypertension A Kirabo, V Fontana, APC De Faria, R Loperena, CL Galindo, J Wu, ... The Journal of clinical investigation 124 (10), 4642-4656, 2014 | 570 | 2014 |
| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 483 | 2024 |
| Global burden of cardiovascular diseases and risks, 1990-2022 GA Mensah, V Fuster, CJL Murray, GA Roth, ... Journal of the American College of Cardiology 82 (25), 2350-2473, 2023 | 481 | 2023 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 445 | 2024 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 430 | 2024 |
| Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 M Naghavi, SE Vollset, KS Ikuta, LR Swetschinski, AP Gray, EE Wool, ... The Lancet 404 (10459), 1199-1226, 2024 | 302 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 291 | 2024 |
| Activation of human T cells in hypertension: studies of humanized mice and hypertensive humans HA Itani, WG McMaster Jr, MA Saleh, RR Nazarewicz, TP Mikolajczyk, ... Hypertension 68 (1), 123-132, 2016 | 278 | 2016 |
| Immune activation caused by vascular oxidation promotes fibrosis and hypertension J Wu, MA Saleh, A Kirabo, HA Itani, KRC Montaniel, L Xiao, W Chen, ... The Journal of clinical investigation 126 (1), 50-67, 2016 | 263 | 2016 |
| Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 mitogen-activated protein kinase J Wu, SR Thabet, A Kirabo, DW Trott, MA Saleh, L Xiao, MS Madhur, ... Circulation research 114 (4), 616-625, 2014 | 262 | 2014 |
| Oligoclonal CD8+ T Cells Play a Critical Role in the Development of Hypertension DW Trott, SR Thabet, A Kirabo, MA Saleh, H Itani, AE Norlander, J Wu, ... Hypertension 64 (5), 1108-1115, 2014 | 258 | 2014 |
| Renal denervation prevents immune cell activation and renal inflammation in angiotensin II–induced hypertension L Xiao, A Kirabo, J Wu, MA Saleh, L Zhu, F Wang, T Takahashi, ... Circulation research 117 (6), 547-557, 2015 | 243 | 2015 |
| Renal Transporter Activation During Angiotensin-II Hypertension is Blunted in Interferon-γ−/− and Interleukin-17A−/− Mice NV Kamat, SR Thabet, L Xiao, MA Saleh, A Kirabo, MS Madhur, E Delpire, ... Hypertension 65 (3), 569-576, 2015 | 231 | 2015 |
| Interleukin-17A regulates renal sodium transporters and renal injury in angiotensin II–induced hypertension AE Norlander, MA Saleh, NV Kamat, B Ko, J Gnecco, L Zhu, BL Dale, ... Hypertension 68 (1), 167-174, 2016 | 212 | 2016 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 193 | 2024 |
| CD70 exacerbates blood pressure elevation and renal damage in response to repeated hypertensive stimuli HA Itani, L Xiao, MA Saleh, J Wu, MA Pilkinton, BL Dale, NR Barbaro, ... Circulation research 118 (8), 1233-1243, 2016 | 172 | 2016 |
| Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation MA Saleh, WG McMaster, J Wu, AE Norlander, SA Funt, SR Thabet, ... The Journal of clinical investigation 125 (3), 1189-1202, 2015 | 169 | 2015 |
| Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat MA Saleh, EI Boesen, JS Pollock, VJ Savin, DM Pollock Hypertension 56 (5), 942-949, 2010 | 152 | 2010 |
| Inhibition of interleukin-17A, but not interleukin-17F, signaling lowers blood pressure, and reduces end-organ inflammation in angiotensin II–induced hypertension MA Saleh, AE Norlander, MS Madhur JACC: Basic to Translational Science 1 (7), 606-616, 2016 | 135 | 2016 |
Meena S. MadhurIndiana University確認したメール アドレス: iu.edu
